T1	Participants 183 195	464 patients
T2	Participants 834 917	Patients were younger than 55 years and had at least one adverse prognostic factor.
T3	Participants 0 171	Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission:
